Innovation

As temperatures start to dip, a pediatrician shares her best advice for helping support children’s immune systems.

Seven weeks. 19 students. One incredible experience. We’re talking about the inaugural Girls Who Code Summer Immersion Program hosted at the company’s Raritan location—and we captured it all on video. Watch as two high schoolers take us behind the scenes.

From a promising alternative for the flu shot to hope for a “universal” vaccine, we take a look at how scientists at Johnson & Johnson are exploring novel ideas for preventing and treating the flu.

The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world’s second largest outbreak of the disease.

If getting healthy is one of your resolutions—and you’ve wondered about bariatric surgery—here are answers to some common questions, including what BMI you really need to have to qualify for the procedure and whether you can expect to gain any weight back.

The company just released its inaugural Diversity & Inclusion Impact Review. We take a look inside its pages to see how the company’s striving every day to build a culture of belonging.

Johnson & Johnson’s Chief Human Resources Officer reveals how the organization stays forward-thinking after 133 years in business, garnering it a spot on Fast Company‘s inaugural Best Workplaces for Innovators list.

Malaria. Newborn jaundice. Hearing loss. These are just some of the health problems that the winners of this year’s Johnson & Johnson Africa Innovation Challenge are tackling by leveraging everything from apps to a smart formula for soap.

It seems pretty simple: curly or straight, fine or thick, right? There’s actually a lot more to your kid’s locks, and understanding the science behind your little one’s unique hair type can help make a big difference when it comes to cleaning and styling. Take this fun quiz to test your smarts.

Despite being one of the oldest viruses known to infect man, there’s been slow progress toward a cure for the disease. But a promising clinical trial, led by Janssen researcher Heather Davis, Ph.D., is sparking hope.